DuChemBIO Co.,Ltd. (KOSDAQ:176750)
South Korea flag South Korea · Delayed Price · Currency is KRW
7,720.00
-700.00 (-8.31%)
At close: Oct 23, 2026

DuChemBIO Financials Overview

Millions KRW. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023
Period EndingJun '26 Dec '25 Dec '24 Dec '23
Revenue
41,50938,57235,60134,695
Revenue Growth
15.90%8.35%2.61%-
Gross Profit
15,69614,23012,23411,797
Operating Income
8,0737,4435,0765,256
Net Income
6,8276,4807,9944,001
Earnings Per Share
240.07228.00297.54149.54
EPS Growth
-8.60%-23.37%98.97%-

Revenue by Geography

Fiscal Year
TTMFY 2025FY 2024FY 2023
Period EndingJun '26 Dec '25 Dec '24 Dec '23
South Korea
41,25438,46035,55534,592
North America
51.2318.025.3759.79
Oceania
-58.8322.0513.28
Asia
132.435.6818.0930.72
Total
41,50938,57235,60134,695

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023
Period EndingJun '26 Dec '25 Dec '24 Dec '23
Cash & Investments
19,02815,45010,6901,981
Total Debt
20,74724,45917,55121,755
Net Cash (Debt)
-1,719-9,009-6,861-19,775
Net Cash Growth
----
Net Cash Per Share
-60.46-317.09-255.39-739.20

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023
Period EndingJun '26 Dec '25 Dec '24 Dec '23
Operating Cash Flow
12,6439,9397,0298,441
Capital Expenditures
-732.1-865.67-1,589-1,147
Free Cash Flow
11,9119,0745,4407,293
Free Cash Flow Growth
81.45%66.81%-25.41%-

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023
Period EndingJun '26 Dec '25 Dec '24 Dec '23
Gross Margin
37.81%36.89%34.36%34.00%
Operating Margin
19.45%19.30%14.26%15.15%
Pretax Margin
17.28%17.26%15.63%11.68%
Profit Margin
16.45%16.80%22.45%11.53%
FCF Margin
28.70%23.52%15.28%21.02%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023
Period EndingOct '26 Dec '25 Dec '24 Dec '23
PE Ratio
32.1641.6429.0137.10
Forward PE
-15.80--
P/FCF Ratio
18.3929.7442.6320.35
PS Ratio
5.287.006.514.28